BTG launches DigiFab in the UK
BTG, a specialist healthcare company, has launched its DigiFab product in the UK.
BTG, a specialist healthcare company, has launched its DigiFab product in the UK.
The product is used to treat patients enduring known or suspected life-threatening toxicity associated with heart conditions.
The launch will be conducted through the firm's international company, Protherics Medicines Development.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company's share price is up 53% over the past year, but fell 0.49% to 342.10p on the day of the announcement.
NR
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
The British railway industry is in rude health – here's why investors should jump aboard
The railway industry has bounced back from the devastating impact of the pandemic and is entering a new phase of development – and profitability
-
Will chancellor Rachel Reeves reverse non-dom inheritance tax changes?
The end of the non-dom tax regime is already causing a UK wealth exodus, data suggests, but chancellor Rachel Reeves may make changes to soften the blow of reforms